Insights and questions arising from studies of a mouse model of Glanzmann thrombasthenia

Thrombosis and Haemostasis

Volumn 82, Issue 2, 1999, Pages 481-485

  Hynes, Richard O ^a,b   Hodivala Dilke, Kairbaan M ^a  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS; ANIMAL MODEL; CONFERENCE PAPER; FETUS MORTALITY; GLANZMANN DISEASE; MOUSE; NONHUMAN; OSTEOLYSIS; PLACENTA DISORDER; PRIORITY JOURNAL;

EID: 0032725055     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1615868     Document Type: Conference Paper

References (59)

1. George, JN, Caen, JP, and Nurden, AT. Glanzmann's thrombasthenia: the spectrum of clinical disease. Blood. 1990;75:1383-1395.
2. Bray, PF. Inherited diseases of platelet glycoproteins: considerations for rapid molecular characterization. Thromb Haemost. 1994;72:492-502.
3. th Ed. William's Hematology. NY: McGraw Hill;1995
4. Kato A. The biologic and clinical spectrum of Glanzmann's Thrombasthenia: implications of integrin αIIbβ3 for its pathogenesis. Crit Rev Oncol Hematol. 1997;26:1-23.
5. Loftus, JC, O'Toole, T., Plow EF, Glass A, Frelinger III AL, Ginsberg MH. A β3 integrin mutation abolishes ligand binding and alters divalent cation-dependent conformation. Science. 1990;249:915-918.
6. Bajt ML, Ginsberg MG, Frelinger III AL, Berndt MC, Loftus JC. A spontaneous mutation of integrin αIIbβ3 (platelet glycoprotein IIb-IIIa) helps define a ligand binding site. 1992;267:3789-3794.
7. Savage B, Saldivar E, Ruggeri ZM. Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell. 1996;84:289-297.
8. Savage B, Almus-Jacobs F, Ruggeri ZM. Specific synergy of multiple substrate-receptor interactions in platelet thrombus formation under flow. Cell. 1998;94:657-666.
9. Ginsberg M, Pierschbacher MD, Ruoslahti E, Marguerie G, Plow E. Inhibition of fibronectin binding to platelets by proteolytic fragments and synthetic peptides, which support fibroblast adhesion. J Biol Chem. 1985;260:3931-3936.
10. Gardner JM, Hynes RO. Interaction of fibronectin with its receptor on platelets. Cell. 1985;42:439-448.
11. Lawler J, Weinstein R, Hynes R O (1988). Cell attachment to thrombospondin: the role of ARG-GLY-ASP, calcium, and integrin receptors. J Cell Biol. 1988;107:2351-61.
12. Varner JA, Brooks, PC, Cheresh DA. The integrin alpha V beta 3: angiogenesis and apoptosis. Cell Adhes Commun. 1995;3:367-374.
13. Strömblad S, Cheresh DA. (1996). Cell adhesion and angiogenesis. Trends in Cell Biol. 1996;6:462-468.
14. Engleman VW, Nickols GA, Ross FP, Horton MA, Griggs DW, Settle SL, Ruminski PG, Teitelbaum SL. A peptidomimetic antagonist of the alpha(v)beta3 integrin inhibits bone resorption in vitro and prevents osteoporosis in vivo. J Clin Invest. 1997;99:2284-2292.
15. Grippes BA, Engleman VW, Settle SL, Delarco J, Ornberg RL, Helfrich MH, Horton MA, Nickols GA. (1996) Antibody to β3 integrin inhibits osteoclast-mediated bone resorption in the thyroparathyroidectomized rat. Endocrinology. 1996;137:918-924.
16. Byzova TV, Rabbani R, D'Souza SE, Plow EF. Role of integrin αvβ3 in vascular biology. Thromb. Haemost. 1998;80:726-734.
17. Felding-Habermann B, Cheresh DA.Vitronectin and its receptors. Curr Opin Cell Biol. 1993;5:864-8.
18. Albelda SM, Mette SA, Elder DE, Stewart R, Damjanovich L, Herlyn M, Buck CA. Integrin distribution in malignant melanoma: association of the beta 3 subunit with tumor progression. Cancer Res. 1990;20:6757-6764
19. Delannet M, Martin F, Bossy B, Cheresh DA, Reichardt LF, Duband JL. Specific roles of the αvβ1, αvβ3, and αvβ5 integrins in avian neural crest cell adhesion and migration on vitronectin. Development. 1994;120:2687-2702.
20. Bader BL, Rayburn H, Crowley D, Hynes RO. Extensive vasculogenesis, angiogenesis and organogenesis precede lethality in mice lacking all αv integrins. Cell. 1998;95:507-519
21. Hodivala-Dilke KM, McHugh K, Tsakiris DA, Rayburn H, Crowley D, Ullman-Culleré, M, Ross FP, Coller BS, Teitelbaum S, Hynes RO. (1999). β3-integrin-deficient mice: a model for Glanzmann thrombasthenia showing placental defects and reduced survival. J Clin Invest. 1999;103:229-238.
22. Zhou Y, Damsky CH, Fisher SJ. Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome. J Clin Invest. 1997;99:2152-64.
23. McHugh KP, Hodivala-Dilke K, Cheng S, Zheng MH, Avioli LV, Ross FP, Hynes RO, Teitelbaum SL. Osteoclasts and osteoblasts in the β3 integrin knockout mouse are dysfunctional. [SOURCE] 1998
24. Noden DM. Embryonic origins and assembly of blood vessels. Am Rev Respir Dis 1989;140:1097-1103.
25. Risau W, Flamme I. Vasculogenesis. Annu Rev Cell Dev Biol. 1995;11:73-91.
26. Risau W. Mechanisms of angiogenesis. Nature. 1997;386:671-674.
27. Folkman J, D'Amore PA. Blood vessel formation: what is its molecular basis? Cell. 1996;87:1153-1155.
28. Hanahan D. Signaling vascular morphogenesis and maintenance . Science. 1997;277:48-50.
29. Beck L, Jr, D'Amore PA. Vascular development: cellular and molecular regulation. Faseb J. 1997;11:365-373.
30. Korpelainen EI, Alitalo K. Signaling angiogenesis and lymphangiogenesis. Curr Opin Cell Biol. 1998;10:159-164.
31. Yancopoulos GD, Klagsbrun M, Folkman J. Vasculogenesis, angiogenesis, and growth factors: ephrins enter the fray at the border. Cell. 1998;93:661-664.
32. Patan, S., Haenni, B. and Burri, P.H. Implementation of intussusceptive microvascular growth in the chicken chorioallantoic membrane (CAM): 1. Pillar formation by folding of the capillary wall. Microvasc Res. 1996a;51:80-98.
33. Patan S, Haenni B, Burri PH. Implementation of intussusceptive microvascular growth in the chicken chorioallantoic membrane (CAM). 2. Pillar formation by capillary fusion. Microvasc Res. 1997;53:33-52.
34. Brooks PC, Stromblad S, Klemke R, Visscher D, Sarkar FH, Cheresh DA. Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin. J Clin Invest. 1995;96:1815-1822.
35. Brooks PC, Clark RA, Cheresh DA. (1994a). Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science. 1994a;264:569-571.
36. Brooks PC, Montgomery AM, Rosenfeld M, Reisfeld RA, Hu T, Klier G, Cheresh DA. Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell. 1994b;79:1157-1164.
37. Brooks PC, Stromblad S, Klemke R, Visscher D, Sarkar FH., Cheresh DA. Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin. J Clin Invest. 1995;96:1815-1822.
38. Brooks PC, Silletti S, von Schalscha TL, Friedlander M, Cheresh DA. Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity. Cell. 1998;92:391-400.
39. Friedlander M, Brooks PC, Shaffer RW, Kincaid CM, Varner JA, Cheresh DA. Definition of two angiogenic pathways by distinct alpha v integrins. Science. 1995;270:1500-1502.
40. Friedlander M, Theesfeld CL, Sugita M, Fruttiger M, Thomas MA, Chang S, Cheresh DA. (1996). Involvement of integrins alpha v beta 3 and alpha v beta 5 in ocular neovascular diseases. Proc Natl Acad Sci U S A. 1996;93:9764-9.
41. Hammes HP, Brownlee M, Jonczyk A, Sutter A, Preissner KT. Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor-type integrins inhibits retinal neovascularization. Nat Med. 1996;2:529-33.
42. Diaz-Gonzalez F, Forsyth J, Steiner B, Ginsberg MH. Transdominant inhibition of integrin function. Mol Biol Cell. 1996;7:1939-1951.
43. Yang JT, Rayburn H, Hynes RO. Embryonic mesodermal defects in alpha 5 integrin-deficient mice. Development. 1993;119:1093-1105.
44. George EL, Georges-Labouesse EN, Patel-King RS, Rayburn H, Hynes RO. Defects in mesoderm, neural tube and vascular development in mouse embryos lacking fibronectin. Development. 1993;119:1079-91.
45. George EL, Baldwin HS, Hynes RO. Fibronectins are essential for heart and blood vessel morphogenesis but are dispensable for initial specification of precursor cells. Blood. 1997;90:3073-3081.
46. Senger DR, Claffey KP, Benes JE, Perruzzi CA, Sergiou AP, Detmar M. Angiogenesis promoted by vascular endothelial growth factor: regulation through alphalbetal and alpha2beta1 integrins. Proc Natl Acad Sci U S A. 1997;94:13612-13617.
47. Chin L, Pomerantz J, Polsky D, Jacobson M, Cohen C, Cordon-Cardo C, Horner II, JW, DePinho RA. Cooperative effects of INK4a and ras in melanoma susceptibility in vivo. Genes and Dev. 1997;11:2822-2834.
48. Bergers G, Hanahan D, Coussens LM. Angiogenesis and apoptosis are cellular parameters of neoplastic progression in transgenic mouse models of tumorigenesis. Int J Dev Biol. 1998;42:995-1002.
49. Wilcox DA, Olsen JC, Ishizawa L, Bray PF, French DL, Steeber DA, Bell WR, Griffith M, White III, GC. (1999). Megakaryocyte-targeted synthesis of the integrin-β3-subunit results in the phenotypic correction of Glanzmann's thrombasthenia. (submitted).
50. Wilcox, DA, Hodivala-Dilke KM, Hynes RO, White II, GC. Of mice and men: detection of a functional murine αIIb-human β3 heterodimer complex on the surface of megakaryocytes derived from retrovirus-transduced bone marrow cells from β3-knockout mice. Blood. 1998;92:2885a.
51. Coburn J, Leong JM, Erban JK. (1993). Integrin αIIbβ3 mediates binding of the Lyme disease agent Borrelia burgdorferi to human platelets. Proc Natl Acad Sci U S A. 1993;90:7059-7063.
52. Coburn J, Barthold SW, Leong JM. Diverse Lyme disease spirochetes bind integrin αIIbβ3 on human platelets. Infect Immun. 1994;62:5559-5561.
53. Coburn J, Magoun L, Bodary Sc, Leong Jm. Integrins αVβ3 and α5β1 Mediate Attachment of Lyme Disease Spirochetes to Human Cells. Infect Immun. 1998;66:1946-1952.
54. Wickham TJ, Mathias P, Cheresh DA, Nemerow GR. Integrins αvβ3 and αvβ5 promote adenovirus internalization but not virus attachment. Cell. 1993;73:309-319.
55. Hebbel RP. Adhesive interactions of sickle erythrocytes with endothelium. J Clin Invest. 1997;99:2561-2564.
56. Panda D, Kundu GC, Lee BI, Peri A, Fohl D, Chackalaparampil I, Mukherjee BB, Li XD, Mukherjee DC, Seides S, Rosenberg J, , Mjkherjee AB. Potential roles of osteopontin and αvβ3 integrin in the development of coronary artery restenosis after angioplasty. Proc Natl Acad Sci U S A. 1997;94:9308-9313.
57. Weerasinghe D, McHugh KP, Ross FP, Brown EJ, Gisler RH, Imhof BA. A role for the αvβ3 integrin in the transmigration of monocytes. J Cell Biol. 1998;142:595-607.
58. Varner JA, Cheresh DA. Integrins and cancer. Curr Opin Cell Biol. 1996;8:724-30:
59. Giancotti FG, Mainiero F. Integrin-mediated adhesion and signaling in tumorigenesis. Biochim Biophys Acta. 1994;1198:47-64.